Galectin Therapeutics
GALT
GALT
33 hedge funds and large institutions have $12.6M invested in Galectin Therapeutics in 2013 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $556K
Holders
33
Holding in Top 10
–
Calls
–
Puts
$556K
Top Buyers
| 1 | +$1.65M | |
| 2 | +$1.56M | |
| 3 | +$1.19M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$813K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$475K |
Top Sellers
| 1 | -$1.52M | |
| 2 | -$1.07M | |
| 3 | -$472K | |
| 4 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
-$209K |
| 5 |
Jane Street
New York
|
-$100K |